S100A9, human, recombinant, full length
- Known as:
- S100A9, H. sapiens, Rec., length
- Catalog number:
- 201SA09
- Product Quantity:
- 5x0.5mg
- Category:
- -
- Supplier:
- ProtEra
- Gene target:
- S100A9 human recombinant full length
Related genes to: S100A9, human, recombinant, full length
- Gene:
- S100A9 NIH gene
- Name:
- S100 calcium binding protein A9
- Previous symbol:
- CAGB, CFAG
- Synonyms:
- P14, MIF, NIF, LIAG, MRP14, MAC387, 60B8AG, CGLB
- Chromosome:
- 1q21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1989-05-19
- Date modifiied:
- 2018-05-02
Related products to: S100A9, human, recombinant, full length
Related articles to: S100A9, human, recombinant, full length
- To identify key genes and shared pathogenic pathways associated with acute pancreatitis-associated acute lung injury (AP-ALI), through bioinformatics analysis, and to provide potential molecular targets for the diagnosis and treatment of AP-ALI. - Source: PubMed
Publication date: 2026/05/22
Chen LingfengGuo FengzhuHong Chunlin - Acute lung injury (ALI) is a complex and life-threatening condition. In severe cases, ALI can progress to acute respiratory distress syndrome (ARDS), which is associated with high mortality. It is characterized by diffuse pulmonary parenchymal inflammation and refractory hypoxemia. Neutrophils, as pivotal immune cells in the lungs, play a critical role in the development and progression of ALI. This study aimed to determine whether S100A9 deletion alleviates LPS-induced ALI by modulating neutrophil activation through the NRF2/HO-1 signaling axis. - Source: PubMed
Publication date: 2026/05/22
Yin ShuangHu XinyuCai HaoJiang RuoxuanLi JialiCheng Yan - Suxiao Jiuxin Pills (SJP), as a classic Chinese patent medicine formula, is clinically used to treat angina pectoris and myocardial ischemia (MI). However, its pharmacodynamic basis and potential molecular mechanisms remain incompletely elucidated. Bioinformatics analysis identified S100A9 as a key MI target, and ligustilide (Lig) (primary active component of SJP) as its specific ligand. - Source: PubMed
Publication date: 2026/05/18
Guo YingLi MengyaoFang ZhiruiLiu TingWang TianyuZhi HuiChen PingWang ShaoxiaChen LuSun WangjieLiu QiWang Hong - This study aimed to evaluate salivary cotinine and S100A8/A9 levels in children exposed to ETS and to examine the relationship between exposure intensity and inflammatory biomarker expression. - Source: PubMed
Publication date: 2026/05/15
Kockanat ArzuAcipinar Sukran - The window of implantation is a critical period for embryo implantation. Ovarian stimulation can disrupt endometrial receptivity, potentially through altered gene expression and downstream protein profiles. However, the impact on the endometrial proteome remains underexplored. Identifying biomarkers of endometrial receptivity may provide an opportunity to develop targeted interventions aimed at improving implantation outcomes. This prospective, case-crossover, open-label study was conducted at the Department of Human Reproduction, Division of Obstetrics and Gynecology, University Medical Centre Ljubljana, Slovenia, from September 2023 to June 2024. The study included 15 women aged <43 years with primary infertility and poor ovarian response. Endometrial samples were collected using a pipelle biopsy during the window of implantation in spontaneous and stimulated cycles and analyzed using protein microarrays targeting 1,466 proteins. Differential protein abundance was assessed using a multi-factorial linear model, including patient-specific effects as an additional factor to account for the paired case-crossover design. Effect sizes are reported as log2-fold changes with corresponding 95% confidence intervals. Differential abundance was defined a priori as |log2FC| > 0.5 with FDR-adjusted p-value < 0.05. Comparison of endometrial samples from spontaneous and stimulated cycles revealed 114 antibodies with differential abundance. Key proteins were associated with immune response (IL-8, proteins S100-A8 and S100-A9, CAMP) and extracellular matrix remodeling (MMP-9). Exploratory KEGG pathway mapping suggested involvement of immune and inflammatory pathways, including cytokine-cytokine receptor interaction and IL-17 signaling. Cluster analysis demonstrated distinct proteomic patterns, with all stimulated-cycle samples showing alterations and a subset of stimulated-cycle samples (40%) exhibiting more pronounced changes. The findings indicate that ovarian stimulation is associated with measurable alterations in the endometrial proteomic profile during the window of implantation. These changes may be relevant to biological pathways involved in endometrial receptivity and implantation. Further studies in larger cohorts are needed to validate the identified candidate markers and determine their clinical relevance for implantation outcomes. Trial registration: ClinicalTrials.gov NCT06804174. - Source: PubMed
Publication date: 2026/05/19
Abdulkhalikova DzhamilyatBan Frangež HelenaBurnik Papler TanjaŠtimpfel MartinVrtačnik Bokal EdaŠalamun Vesna